International Journal of Hematology and Oncology
2022 , Vol 32 , Num 3
Kemal EKICI, Mehmet KULOGLU, Aysun Ozsoy ATA, Ozcan ATAHAN, Osman TIRYAKIOGLU
A Dosimetric Comparison of 7 Field IMRT, 9 Field IMRT, VMAT and 3-D Conformal Radiotherapy for the Treatment of Localized Intermediate Risk Prostate Cancer. UHOD , 2022 , 32 , 133-140
Eyyup CAVDAR, Yakup IRIAGAC, Kubilay KARABOYUN, Okan AVCI, Meltem OZNUR, Erdogan Selcuk SEBER Prognostic Role of Lymphovascular Invasion and Perineural Invasion in Breast Cancer Treated with Neoadjuvant Chemotherapy. UHOD , 2022 , 32 , 141-149
Osman KUPIK, Murat TUNCEL, Sercan AKSOY, Pinar O. KIRATLI, Meltem G. AKPINAR, Kadri ALTUNDAG, Figen B. DEMIRKAZIK, Belkis ERBAS 18F FDG PET/CT after Neoadjuvant Chemotherapy and Pathological Responses are Predictive Factors for Disease-Free Survival and Overall Survival in Patients with Locally Advanced Breast Cancer: A Prospective Study. UHOD , 2022 , 32 , 150-158
Berrin BENLI YAVUZ, Necdet POYRAZ, Gul KANYILMAZ, Meryem AKTAN, Ismail H. TUNCEZ, Mehmet KOC The Influence of Hormone Therapy on the Development of Pulmonary Fibrosis after Radiotherapy in Patients with Breast Cancer. UHOD , 2022 , 32 , 159-165
Zumrut Arda KAYMAK, Emine Elif OZKAN, Ibrahim COBANBAS The Role of Systemic Immune-Inflammation Indices, Dosimetric and Surgical Parameters in the Prediction of Breast Fibrosis after Whole Breast Radiotherapy. UHOD , 2022 , 32 , 166-173
Yasemin SENGUN, Melek Gamze AKSU, Rahmi Atil AKSOY, Mine GENC, Sema SEZGIN GOKSU, Muhittin YAPRAK, Aylin Fidan KORCUM Neoadjuvant Chemoradiotherapy in Rectal Cancer: A single Institution Experience from Turkey. UHOD , 2022 , 32 , 174-181
Gonca ALTINISIK INAN, Ipek Pinar ARAL, Feyza Yasar DASGIN, Tarik KARGIOGLU, Huseyin Furkan OZTURK, Suheyla AYTAC ARSLAN, Yilmaz TEZCAN Evaluation of Dose Distribution Due to Change in Bowel Position in Patients Treated with SBRT for a Target Lesion Neighboring the Intestine. UHOD , 2022 , 32 , 182-187
Mehmet KIZILKAYA, Mine GENC, Melek Gamze AKSU, Timur KOCA, Aylin Fidan KORCUM Results of Screening Oncology Patients for COVID-19 Before Radiotherapy: Single Center Experience. UHOD , 2022 , 32 , 188-190
Eyyup CAVDAR, Yakup IRIAGAC, Kubilay KARABOYUN, Okan AVCI, Meltem OZNUR, Erdogan Selcuk SEBER Prognostic Role of Lymphovascular Invasion and Perineural Invasion in Breast Cancer Treated with Neoadjuvant Chemotherapy. UHOD , 2022 , 32 , 141-149
Osman KUPIK, Murat TUNCEL, Sercan AKSOY, Pinar O. KIRATLI, Meltem G. AKPINAR, Kadri ALTUNDAG, Figen B. DEMIRKAZIK, Belkis ERBAS 18F FDG PET/CT after Neoadjuvant Chemotherapy and Pathological Responses are Predictive Factors for Disease-Free Survival and Overall Survival in Patients with Locally Advanced Breast Cancer: A Prospective Study. UHOD , 2022 , 32 , 150-158
Berrin BENLI YAVUZ, Necdet POYRAZ, Gul KANYILMAZ, Meryem AKTAN, Ismail H. TUNCEZ, Mehmet KOC The Influence of Hormone Therapy on the Development of Pulmonary Fibrosis after Radiotherapy in Patients with Breast Cancer. UHOD , 2022 , 32 , 159-165
Zumrut Arda KAYMAK, Emine Elif OZKAN, Ibrahim COBANBAS The Role of Systemic Immune-Inflammation Indices, Dosimetric and Surgical Parameters in the Prediction of Breast Fibrosis after Whole Breast Radiotherapy. UHOD , 2022 , 32 , 166-173
Yasemin SENGUN, Melek Gamze AKSU, Rahmi Atil AKSOY, Mine GENC, Sema SEZGIN GOKSU, Muhittin YAPRAK, Aylin Fidan KORCUM Neoadjuvant Chemoradiotherapy in Rectal Cancer: A single Institution Experience from Turkey. UHOD , 2022 , 32 , 174-181
Gonca ALTINISIK INAN, Ipek Pinar ARAL, Feyza Yasar DASGIN, Tarik KARGIOGLU, Huseyin Furkan OZTURK, Suheyla AYTAC ARSLAN, Yilmaz TEZCAN Evaluation of Dose Distribution Due to Change in Bowel Position in Patients Treated with SBRT for a Target Lesion Neighboring the Intestine. UHOD , 2022 , 32 , 182-187
Mehmet KIZILKAYA, Mine GENC, Melek Gamze AKSU, Timur KOCA, Aylin Fidan KORCUM Results of Screening Oncology Patients for COVID-19 Before Radiotherapy: Single Center Experience. UHOD , 2022 , 32 , 188-190